Results of the Dyslipidemia International Study (DYSIS)-Middle East: Clinical Perspective on the Prevalence and Characteristics of Lipid Abnormalities in the Setting of Chronic Statin Treatment

2012, Cardiovascular diseases (CVDs) Fact sheet no. 317

TM Ramahi, 2010, Cardiovascular disease in the Asia Middle East region: global trends and local implications, Asia Pac J Public Health, 22, 83S, 10.1177/1010539510373034

2011, Saudi Arabia.

2011, Lebanon

C Baigent, 2005, Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins, Lancet, 366, 1267, 10.1016/S0140-6736(05)67394-1

P Deedwania, 2006, Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study, Lancet, 368, 919, 10.1016/S0140-6736(06)69292-1

PM Kearney, 2008, Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis, Lancet, 371, 117, 10.1016/S0140-6736(08)60104-X

TJ Wilt, 2004, Effectiveness of statin therapy in adults with coronary heart disease, Arch Intern Med, 164, 1427, 10.1001/archinte.164.13.1427

MJ Cziraky, 2008, Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting, J Manag Care Pharm, 14, 28

RW Nesto, 2005, Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome, Am J Cardiovasc Drugs, 5, 379, 10.2165/00129784-200505060-00005

K Kotseva, 2011, Lessons from EUROASPIRE i, II and III Surveys. Heart Metab, 50, 32

K Kotseva, 2008, Treatment potential for cholesterol management in patients with coronary heart disease in 15 European countries: findings from the EUROASPIRE II survey, Atherosclerosis, 197, 710, 10.1016/j.atherosclerosis.2007.07.004

K Kotseva, 2009, Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries, Lancet, 373, 929, 10.1016/S0140-6736(09)60330-5

J Perk, 2012, European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) : The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by Representatives of Nine Societies and by Invited Experts), Int J Behav Med

AK Gitt, 2012, Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada, Eur J Prev Cardiol, 19, 221, 10.1177/1741826711400545

SM Grundy, 2004, Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines, Circulation, 110, 227, 10.1161/01.CIR.0000133317.49796.0E

WC Roberts, 1997, The rule of 5 and the rule of 7 in lipid-lowering by statin drugs, Am J Cardiol, 80, 106, 10.1016/S0002-9149(97)00298-1

AL Catapano, 2011, ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Atherosclerosis, 217, 3

M Moss, 2003, An appraisal of multivariable logistic models in the pulmonary and critical care literature, Chest, 123, 923, 10.1378/chest.123.3.923

B Eber, 2012, Can LDL-cholesterol targets be achieved in a population at high risk? Results of the non-interventional study ACT II, Curr Med Res Opin, 28, 1447, 10.1185/03007995.2012.717919

TR Bandgar, 2011, Managing dyslipidaemia: evolving role of combination therapy, J Indian Med Assoc, 109, 549

MK Ito, 2012, Dyslipidemia: management using optimal lipid-lowering therapy, Ann Pharmacother, 46, 1368, 10.1345/aph.1R127

H Boumedjout, 2012, Cardiovascular diseases on the increase in Arab states, Nature Middle East

NA Al-Baghli, 2010, Awareness of cardiovascular disease in eastern Saudi Arabia, 10.4103/1319-1683.68784

NM Shara, 2010, Cardiovascular disease in Middle Eastern women, Nutr Metab Cardiovasc Dis, 20, 412, 10.1016/j.numecd.2010.01.013

DC Jr Goff, 2006, Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium, Circulation, 113, 647, 10.1161/CIRCULATIONAHA.105.552737